Human protein kills malaria causing parasite

Share Canberra's trusted news:

A RESEARCH team from ANU and the University of Queensland has designed and made a molecule derived from a human protein that kills the parasite which causes malaria. 

Lead research Brendan McMorran says the team is a step closer to developing a new and effective treatment for malaria.
Treatments for malaria, a disease that kills a person every 90 seconds, are becoming less effective because of drug resistance and there is a risk to the future control of the disease.

Lead researcher associate Prof Brendan McMorran from ANU says the team is a step closer to developing a new and effective treatment for malaria.

“We have designed and created a small fragment of a human protein called Platelet factor 4, known as PF4, that can kill the microbial parasite that causes malaria, Plasmodium,” he says.

“PF4, which my research group at ANU identified in previous work, is the only human protein known to kill malarial parasites.”

The protein is relatively large and not suited to use as a treatment, so the team copied parts of the protein that are critical for terminating the malarial parasites into a smaller molecule, otherwise known as a peptide.

“We have shown that this peptide kills the parasite in a way that is completely different to how current antimalarial drugs work,” he says.

“This is important because finding new ways to kill the parasite will help us overcome the drug-resistance problems.”

The study involves expertise from several disciplines from the John Curtin School of Medical Research, the ANU Research School of Biology and the Institute for Molecular Bioscience at the University of Queensland.

The researchers tested the peptide’s effectiveness at killing the malarial parasite cultured in human red cells under laboratory conditions.

The team will develop more potent versions of the peptide that can be used as new treatments for malaria.

“To do this, we plan to modify the peptide to include new functions that target other vulnerable parts of the parasite, and make the peptide more suited to being administered to people,” Dr McMorran says.

The research is published in “Cell Chemical Biology“.

Who Can You Trust?

In a world beleaguered by spin and confused messages, there's never been more need for diverse, trustworthy, independent journalism in Canberra.

Who can you trust? Well, for more than 25 years, "CityNews" has proudly been an independent, free, family-owned news magazine, serving the national capital with quality, integrity and authority. Through our weekly magazine and daily through our digital platforms, we constantly and reliably deliver high-quality and diverse opinion, news, arts, socials and lifestyle columns.

If you trust our work online and believe in the power of independent voices, I encourage you to make a small contribution.

Every dollar of support will be invested back into our journalism so we can continue to provide a valuably different view of what's happening around you and keep citynews.com.au free.

Click here to make your donation and you will be supporting the future of journalism and media diversity in the ACT.

Thank you,

Ian Meikle, editor

Previous articleFyshwick escort agencies forced to shut
Next articleMacklin / The hungry hidden behind the billions

Leave a Reply